195 related articles for article (PubMed ID: 3080635)
1. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
4. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
5. Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability.
Takiguchi M; Ting JP; Buessow SC; Boyer C; Gillespie Y; Frelinger JA
Eur J Immunol; 1985 Aug; 15(8):809-14. PubMed ID: 2411569
[TBL] [Abstract][Full Text] [Related]
6. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
Kelley VE; Fiers W; Strom TB
J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
[TBL] [Abstract][Full Text] [Related]
7. Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines.
Virelizier JL; Perez N; Arenzana-Seisdedos F; Devos R
Eur J Immunol; 1984 Jan; 14(1):106-8. PubMed ID: 6420168
[TBL] [Abstract][Full Text] [Related]
8. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma induces HLA-DR expression by thyroid epithelium.
Todd I; Pujol-Borrell R; Hammond LJ; Bottazzo GF; Feldmann M
Clin Exp Immunol; 1985 Aug; 61(2):265-73. PubMed ID: 3930110
[TBL] [Abstract][Full Text] [Related]
10. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
11. Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines.
Basta PV; Sherman PA; Ting JP
J Immunol; 1987 Feb; 138(4):1275-80. PubMed ID: 3027177
[TBL] [Abstract][Full Text] [Related]
12. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
[TBL] [Abstract][Full Text] [Related]
13. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
Ziai MR; Imberti L; Tongson A; Ferrone S
Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
Masuyama J; Minato N; Kano S
J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
[TBL] [Abstract][Full Text] [Related]
17. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
18. Modulation of expression of class II histocompatibility antigens by secretion of a cellular inhibitor in K562 leukemic cells.
Krief P; Boucheix C; Billard C; Mishal Z; Van Agthoven A; Fiers W; Azzarone B
Eur J Immunol; 1987 Jul; 17(7):1021-5. PubMed ID: 3111856
[TBL] [Abstract][Full Text] [Related]
19. Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma.
Gerrard TL; Dyer DR; Zoon KC; zur Nedden D; Siegel JP
J Immunol; 1988 May; 140(10):3450-5. PubMed ID: 2966196
[TBL] [Abstract][Full Text] [Related]
20. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
Pfizenmaier K; Bartsch H; Scheurich P; Seliger B; Ucer U; Vehmeyer K; Nagel GA
Cancer Res; 1985 Aug; 45(8):3503-9. PubMed ID: 3160456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
